Edwards Lifesciences Corp (EW)
Data as of , from SEC Form 4 filings.
See up to 3 months of EW. The 7-day demo opens the 1M and 3M ranges and puts EW on your watchlist.
Start 7-day demoLatest EW insider trades
Daniel J. Lippis - OfficerOpen-market sale$53K- Daniel J. Lippis
About Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp files with the SEC under CIK 0001099800 and is classified as orthopedic, prosthetic and surgical appliances and supplies. It is grouped with Health Care companies on this site.
EW Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 50,780 | $4.54M |
| Option exercise | 10 | 86,570 | |
| Tax withholding / forfeiture | 4 | 1,574 | |
EW insider transactions (Form 4)
73116 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel J. Lippis - Officer | Option exercise | Common Stock | 619 | $72.68 | $45K | |
| Daniel J. Lippis - Officer | Open-market sale | Common Stock | 619 | $85.65 | $53K | |
| Daniel J. Lippis - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | - | |
| Wayne Markowitz - Officer | Tax withholding / forfeiture | Common Stock | 355 | $86.77 | $31K | |
| Wayne Markowitz - Officer | Tax withholding / forfeiture | Common Stock | 568 | $84.37 | $48K | |
| Andrew M. Dahl - Officer | Tax withholding / forfeiture | Common Stock | 253 | $84.37 | $21K | |
| Daveen Chopra - Officer | Tax withholding / forfeiture | Common Stock | 398 | $86.77 | $35K | |
| Daniel J. Lippis - Officer | Option exercise | Common Stock | 619 | $72.68 | $45K | |
| Daniel J. Lippis - Officer | Open-market sale | Common Stock | 619 | $87.51 | $54K | |
| Daniel J. Lippis - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | - | |
| Andrew M. Dahl - Officer | Open-market sale | Common Stock | 544 | $91.06 | $50K | |
 Annette Bruls - Officer | Open-market sale | Common Stock | 2,644 | $89.98 | $238K | |
| Daveen Chopra - Officer | Option exercise | Common Stock | 31,800 | $72.68 | $2.31M | |
| Daveen Chopra - Officer | Open-market sale | Common Stock | 1,154 | $91.76 footnote F1 | $106K | |
| Daveen Chopra - Officer | Open-market sale | Common Stock | 30,646 | $90.99 footnote F2 | $2.79M | |
| Daveen Chopra - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 31,800 | $0.00 | - | |
| ||||||
| Wayne Markowitz - Officer | Open-market sale | Common Stock | 1,240 | $91.47 | $113K | |
| Daniel J. Lippis - Officer | Option exercise | Common Stock | 619 | $72.68 | $45K | |
| Daniel J. Lippis - Officer | Open-market sale | Common Stock | 619 | $92.03 | $57K | |
| Daniel J. Lippis - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | - | |
| Wayne Markowitz - Officer | Open-market sale | Common Stock | 146.31 | $86.03 | $13K | |
| Wayne Markowitz - Officer | Option exercise | Common Stock | 9,628 | $74.02 | $713K | |
| Wayne Markowitz - Officer | Open-market sale | Common Stock | 9,628 | $85.06 | $819K | |
| Wayne Markowitz - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 9,628 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Gift | Common Stock | 319.65 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Gift | Common Stock | 319.65 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Open-market sale | Common Stock | 2,921 | $83.93 | $245K | |
| Annette Bruls - Officer | Tax withholding / forfeiture | Common Stock | 109 | $92.21 | $10K | |
 Theodora Mistras - Officer | Grant or award | Common Stock | 87,595 footnote F1 | $0.00 | - | |
| Theodora Mistras - Officer | Grant or award | Common Stock | 12,325 footnote F2 | $0.00 | - | |
| Theodora Mistras - Officer | Grant or award | Employee Stock Option (Right to Acquire) | 61,800 | $0.00 | - | |
| Theodora Mistras - Officer | Grant or award | Performance Rights | 12,325 | $0.00 | - | |
| ||||||
| Daniel J. Lippis - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | - | |
| Daniel J. Lippis - Officer | Option exercise | Common Stock | 619 | $72.68 | $45K | |
| Daniel J. Lippis - Officer | Open-market sale | Common Stock | 619 | $91.70 | $57K | |
| Daniel J. Lippis - Officer | Tax withholding / forfeiture | Common Stock | 377 | $95.18 | $36K | |
| Daniel J. Lippis - Officer | Option exercise | Common Stock | 619 | $72.68 | $45K | |
| Daniel J. Lippis - Officer | Open-market sale | Common Stock | 619 | $91.40 footnote F2 | $57K | |
| Daniel J. Lippis - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 619 | $0.00 | - | |
| ||||||
| Bernard J. Zovighian - Officer | Open-market sale | Common Stock | 523 | $87.92 | $46K | |
| Andrew M. Dahl - Officer | Open-market sale | Common Stock | 567.53 | $86.08 | $49K | |
| Donald E. Bobo Jr. - Officer | Open-market sale | Common Stock | 23,145 | $86.42 footnote F1 | $2.00M | |
| ||||||
| Daveen Chopra - Officer | Open-market sale | Common Stock | 1,500 | $84.60 footnote F1 | $127K | |
| ||||||
| Daniel J. Lippis - Officer | Option exercise | Employee Stock Option (Right to Acquire) | 620 | $0.00 | - | |
| Daniel J. Lippis - Officer | Option exercise | Common Stock | 620 | $72.68 | $45K | |
| Daniel J. Lippis - Officer | Open-market sale | Common Stock | 620 | $81.14 | $50K | |
| Donald E. Bobo Jr. - Officer | Open-market sale | Common Stock | 8,000 | $81.82 | $655K | |
| Donald E. Bobo Jr. - Officer | Open-market sale | Common Stock | 9,968 | $82.07 footnote F1 | $818K | |
| ||||||
| Donald E. Bobo Jr. - Officer | Option exercise | Common Stock | 13,457 footnote F1 | $0.00 footnote F1 | - | |
| Donald E. Bobo Jr. - Officer | Option exercise | Performance Rights | 13,457 | $0.00 | - | |
| Donald E. Bobo Jr. - Officer | Tax withholding / forfeiture | Common Stock | 7,469 | $79.96 | $597K | |
| ||||||
| Daveen Chopra - Officer | Tax withholding / forfeiture | Common Stock | 7,538 | $79.96 | $603K | |
| Daveen Chopra - Officer | Option exercise | Common Stock | 13,583 footnote F1 | $0.00 footnote F1 | - | |
| Daveen Chopra - Officer | Option exercise | Performance Rights | 13,583 | $0.00 | - | |
| ||||||
 Scott B. Ullem - Officer | Tax withholding / forfeiture | Common Stock | 11,004 | $79.96 | $880K | |
| Scott B. Ullem - Officer | Option exercise | Common Stock | 19,830 footnote F1 | $0.00 footnote F1 | - | |
| Scott B. Ullem - Officer | Option exercise | Performance Rights | 19,830 | $0.00 | - | |
| ||||||
| Wayne Markowitz - Officer | Grant or award | Common Stock | 5,200 footnote F1 | $0.00 | - | |
| Wayne Markowitz - Officer | Tax withholding / forfeiture | Common Stock | 264 | $83.20 | $22K | |
| Wayne Markowitz - Officer | Tax withholding / forfeiture | Common Stock | 226 | $82.76 | $19K | |
| Wayne Markowitz - Officer | Open-market sale | Common Stock | 593 | $79.73 | $47K | |
| Wayne Markowitz - Officer | Grant or award | Employee Stock Option (Right to Acquire) | 26,400 | $0.00 | - | |
| Wayne Markowitz - Officer | Grant or award | Performance Rights | 5,200 | $0.00 | - | |
| ||||||
| Bernard J. Zovighian - Officer | Tax withholding / forfeiture | Common Stock | 4,153 | $83.20 | $346K | |
| Bernard J. Zovighian - Officer | Gift | Common Stock | 4,222 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Tax withholding / forfeiture | Common Stock | 5,398 | $82.76 | $447K | |
| Bernard J. Zovighian - Officer | Gift | Common Stock | 5,489 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Gift | Common Stock | 4,222 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Gift | Common Stock | 5,489 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Grant or award | Common Stock | 43,800 footnote F1 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Grant or award | Employee Stock Option (Right to Acquire) | 245,300 | $0.00 | - | |
| Bernard J. Zovighian - Officer | Grant or award | Performance Rights | 43,800 | $0.00 | - | |
| ||||||
| Daniel J. Lippis - Officer | Tax withholding / forfeiture | Common Stock | 362 | $79.96 | $29K | |
Item 5.02
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 5.02, 7.01
Recent EW Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Dahl Andrew M. | Officer | 544 | $50K | View on EDGAR | |
| Bruls Annette | Officer | 2,644 | $238K |
Stock trades in EW disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Josh GottheimerDemocrat, NJ-05 | Sale |
EW insider trading FAQ
What is the latest insider trade for EW?
Edwards Lifesciences Corp (EW) had 13 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for EW runs to 116 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EW stock?
No insider purchases of EW were filed in the last 90 days.
How many insiders are selling EW stock?
11 insider sales of EW were filed in the last 90 days, totaling $4.54M.
Where can I see EW SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EW Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel J. Lippis view on EDGAR
- - Wayne Markowitz view on EDGAR
- - Andrew M. Dahl view on EDGAR
- - Daveen Chopra view on EDGAR
- - Daniel J. Lippis view on EDGAR
- - Andrew M. Dahl view on EDGAR
- - Annette Bruls view on EDGAR
- - Daveen Chopra view on EDGAR
- - Wayne Markowitz view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where EW's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EW with a 7-day demo
- EW on your watchlist
- Every EW Form 4 filing on record
- Up to 3 months of EW price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
